Anti‐CD20 mAb maintenance therapy vs observation
Treatment discontinuation · people with chronic lymphocytic leukaemia
Anti‐CD20 mAb maintenance therapy showed no clear difference in treatment discontinuation compared with observation (low certainty).
1 finding from 1 review
- Risk ratio 0.93 [0.72, 1.2]6 studies · 1321 participantsLow